Hirschberg, Germany

Johannes Aufenanger

This inventor holds 2 USPTO granted patents. Top assignees: Boehringer Mannheim Gmbh, Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte. Active years: 1993-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes Aufenanger. Retrieved from https://idiyas.com/inventor/johannes-aufenanger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1993-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Johannes Aufenanger

Introduction

Johannes Aufenanger is a notable inventor based in Hirschberg, Germany. He has made significant contributions to the field of medical technology, particularly in the area of cholesterol measurement and penile tissue health. With a total of two patents to his name, Aufenanger's work has the potential to impact healthcare practices significantly.

Latest Patents

One of Aufenanger's latest patents is a method for determining the relative amounts of all cholesterol-containing lipoproteins in body fluids. This invention involves electrophoretically separating lipoproteins from a body fluid sample on a thin layer carrier matrix. The process includes incubating the carrier matrix with cholesterol esterase and cholesterol dehydrogenase to form a provable complex. This innovative method allows for the simultaneous determination of HDL, LDL, VLDL, and LP (X)-cholesterol in body fluids with high accuracy, even at small concentrations. The thin layer matrices obtained through electrophoresis are easy to handle and record, making this method practical for clinical use.

Another significant patent by Aufenanger addresses the prevention of degenerative changes in penile tissue. This invention utilizes TXA2 receptor antagonists to prepare pharmaceutical compositions aimed at preventing such degenerative changes. This work highlights Aufenanger's commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout his career, Aufenanger has worked with prominent companies in the medical field, including Immuno Aktiengesellschaft für Chemisch-medizinische Produkte and Boehringer Mannheim GmbH. His experience in these organizations has contributed to his expertise and innovative capabilities in medical technology.

Collaborations

Johannes Aufenanger has collaborated with notable individuals in his field, including Johannes Pill and Thomas Konrad. These partnerships have likely fostered a creative environment for innovation and development in his projects.

Conclusion

Johannes Aufenanger's contributions to medical technology through his patents demonstrate his innovative spirit and dedication to improving healthcare. His work in cholesterol measurement and tissue health prevention showcases the potential for significant advancements in medical practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…